Ch 12 Cancer Biology Flashcards
Which cancer originates from connective tissue?
a. Osteogenic sarcoma
c. Multiple myeloma
b. Basal cell carcinoma
d. Adenocarcinoma
ANS: A
Cancers arising from connective tissue usually have the suffix -sarcoma. The remaining
options are not cancers that originate in the connective tissue and, in addition, are lacking
the common suffix.
PTS: 1 REF: Page 364
Carcinoma refers to abnormal cell proliferation originating from which tissue origin?
a. Blood vessels
c. Connective tissue
b. Epithelial cells
d. Glandular tissue
ANS: B
Only cancers arising from epithelial cells are called carcinomas.
PTS: 1 REF: Page 364
Carcinoma in situ is characterized by which changes?
a. Cells have broken through the local basement membrane.
b. Cells have invaded immediate surrounding tissue.
c. Cells remain localized in the glandular or squamous cells.
d. Cellular and tissue alterations indicate dysplasia.
ANS: C
Carcinoma in situ (CIS) refers to preinvasive epithelial malignant tumors of glandular or
squamous cell origin. These early stage cancers are localized to the epithelium and have
not broken through the local basement membrane or invaded the surrounding tissue.
Dysplasia refers to changes in mature cell structure.
PTS: 1 REF: Page 364
Which term is used to describe a muscle cell showing a reduced ability to form new
muscle while appearing highly disorganized?
a. Dysplasia
c. Myoplasia
b. Hyperplasia
d. Anaplasia
ANS: D
Anaplasia is defined as the loss of cellular differentiation, irregularities of the size and
shape of the nucleus, and the loss of normal tissue structure. In clinical specimens,
anaplasia is recognized by a loss of organization and a significant increase in nuclear size
with evidence of ongoing proliferation. The remaining options refer to specific changes in
the cell.
PTS: 1 REF: Pages 368-369
What are tumor cell markers?
a. Hormones, enzymes, antigens, and antibodies that are produced by cancer cells
b. Receptor sites on tumor cells that can be identified and marked
c. Cytokines that are produced against cancer cells
d. Identification marks that are used in administering radiation therapy
ANS: A
Tumor (biologic) markers are substances produced by both benign and malignant cells that
are found either in or on the tumor cells or in the blood, spinal fluid, or urine. Tumor
markers may include hormones, enzymes, genes, antigens, and antibodies. The other
options do not accurately describe examples of tumor markers and their function.
PTS: 1 REF: Pages 365-366
The function of the tumor cell marker is to:
a. Provide a definitive diagnosis of cancer.
b. Treat certain types of cancer.
c. Predict where cancers will develop.
d. Screen individuals at high risk for cancer
ANS: D
Screening and identifying individuals at high risk for cancer are ways tumor markers can
be used. These markers are not used to definitively diagnosis or treat cancer and are not
useful in predicting specific sites of cancer development.
Which statement supports the hypothesis that intestinal polyps are benign neoplasms and
the first stage in the development of colon cancer?
a. Cancer cells accumulate slower than noncancer cells.
b. An accumulation of mutations in specific genes is required for the development of
cancer.
c. Tumor invasion and metastasis progress more slowly in the gastrointestinal tract.
d. Apoptosis is triggered by diverse stimuli, including excessive growth.
ANS: B
Multiple genetic mutations are required for the evolution of full-blown cancer. The
remaining options do not address the progression of benign to metastatic tumors.
PTS: 1 REF: Pages 372-373
Autocrine stimulation is the ability of cancer cells to:
a. Stimulate angiogenesis to create their own blood supply.
b. Encourage secretions that turn off normal growth inhibitors.
c. Secrete growth factors that stimulate their own growth.
d. Divert nutrients away from normal tissue for their own use.
ANS: C
Cancer cells must have mutations that enable them to proliferate in the absence of external
growth signals. To achieve this, some cancers acquire the ability to secrete growth factors
that stimulate their own growth, a process known as autocrine stimulation. The remaining
options do not describe autocrine stimulation.
PTS: 1 REF: Page 380
Apoptosis is a(an):
a. Normal mechanism for cells to self-destruct when growth is excessive
b. Antigrowth signal activated by the tumor-suppressor gene Rb
c. Mutation of cell growth stimulated by the TP53 gene
d. Transformation of cells from dysplasia to anaplasia
ANS: A
Normal cells have a mechanism that causes them to self-destruct when growth is excessive
and cell cycle checkpoints have been ignored. Diverse stimuli, including normal
development and excessive growth, trigger this self-destruct mechanism, called apoptosis.
The remaining options do not describe apoptosis.
PTS: 1 REF: Page 381
Many cancers create a mutation of ras. ras is a(an):
a. Tumor-suppressor gene
b. Growth-promoting gene
c. Intracellular-signaling protein that regulates cell growth
d. Cell surface receptor that allows signaling to the nucleus concerning cell growth
ANS: C
Up to one-third of all cancers have an activating mutation in the gene for an intracellular
signaling protein called ras. This mutant ras stimulates cell growth even when growth
factors are missing. The remaining options do not describe ras.
PTS: 1 REF: Page 380
Oncogenes are genes that are capable of:
a. Undergoing mutation that directs the synthesis of proteins to accelerate the rate of
tissue proliferation
b. Directing synthesis of proteins to regulate growth and to provide necessary
replacement of tissue
c. Encoding proteins that negatively regulate the synthesis of proteins to slow or halt
the replacement of tissue
d. Undergoing mutation that directs malignant tissue toward blood vessels and lymph
nodes for metastasis
ANS: A
Oncogenes are mutant genes that, before mutation, direct synthesis of proteins that
positively regulate (accelerate) proliferation. The remaining options do not describe
oncogenes.
PTS: 1 REF: Page 374
Burkitt lymphomas designate a chromosome that has a piece of chromosome 8 fused to a
piece of chromosome 14. This is an example of which mutation of normal genes to
oncogenes?
a. Point mutation
c. Gene amplification
b. Chromosome translocation
d. Chromosome fusion
ANS: B
Chromosome translocations, in which a piece of one chromosome is translocated to
another chromosome, can activate oncogenes. One of the best examples is the t(8;14)
translocation found in many Burkitt lymphomas; t(8;14) designates a chromosome that has
a piece of chromosome 8 fused to a piece of chromosome 14. The remaining options are
not best depicted by a Burkitt lymphoma.
PTS: 1 REF: Pages 375-376
In childhood neuroblastoma, the N-myc oncogene undergoes which type of mutation of normal gene to oncogene? a. Point mutation c. Gene amplification b. Chromosome fusion d. Chromosome translocation
ANS: C
Amplifications are the result of the duplication of a small piece of a chromosome over and
over again; consequently, instead of the normal two copies of a gene, tens or even
hundreds of copies are present (see Chapter 4). The N-myc oncogene is amplified in 25%
of childhood neuroblastoma.
PTS: 1 REF: Page 376
What aberrant change causes the abnormal growth in retinoblastoma?
a. Proto-oncogenes are changed to oncogenes.
b. The tumor-suppressor gene is turned off.
c. Genetic amplification causes the growth.
d. Chromosomes 9 and 21 are fused.
ANS: B
One of the first discovered tumor-suppressor genes, the retinoblastoma (Rb) gene,
normally strongly inhibits the cell division cycle. When it is inactivated, the cell division
cycle can proceed unchecked. The Rb gene is mutated in childhood retinoblastoma. The
remaining options do not describe the abnormal growth in retinoblastoma.
PTS: 1 REF: Page 376
Two “hits” are required to inactivate tumor-suppressor genes because:
a. Each allele must be altered, and each person has two copies, or alleles, of each
gene, one from each parent.
b. The first hit stops tissue growth, and the second hit is needed to cause abnormal
tissue growth.
c. Tumor-suppressor genes are larger than proto-oncogenes, requiring two hits to
effect carcinogenesis.
d. The first hit is insufficient to cause enough damage to cause a mutation
ANS: A
A single genetic event can activate an oncogene, acting in a dominant manner in the cell.
However, each person has two copies, or alleles, of each gene, one from each parent.
Therefore two hits are required to inactivate the two alleles of a tumor-suppressor gene,
allowing the process to become active. The remaining options do not describe the reason
two hits are required.
PTS: 1 REF: Page 376 | Page 378
The ras gene converts from a proto-oncogene to an oncogene by:
a. Designating a chromosome that has a piece of one chromosome fused to a piece of
another chromosome
b. Duplicating a small piece of a chromosome, repeatedly making numerous copies
c. Altering one or more nucleotide base pairs
d. Promoting proliferation of growth signals by impairing tumor-suppressor genes
ANS: C
A point mutation is the alteration of one or a few nucleotide base pairs. This type of
mutation can have profound effects on the activity of proteins. A point mutation in the ras
gene converts it from a regulated proto-oncogene to an unregulated oncogene, an
accelerator of cellular proliferation. The remaining options do not describe point mutation
as it affects the conversion of a ras gene.
PTS: 1 REF: Page 375
How do cancer cells use the enzyme telomerase?
a. To repair the telomeres to restore somatic cell growth
b. As an intracellular signaling chemical to stimulate cell division
c. To switch off the telomerase to enable cells to divide indefinitely
d. To switch on the telomerase to enable cells to divide indefinitely
ANS: D
Cancer cells, when they reach a critical age, somehow activate telomerase to restore and
maintain their telomeres and thereby make it possible for cells to divide over and over
again. The remaining options do not describe how cancer cells use telomerase.
PTS: 1 REF: Page 382
What are characteristics of benign tumors?
a. Benign tumors invade local tissues.
b. Benign tumors spread through the lymph nodes.
c. Benign tumors cause systemic symptoms.
d. Benign tumors include the suffix -oma.
ANS: D
Benign tumors are usually encapsulated and well-differentiated. They retain some normal
tissue structure and do not invade the capsules surrounding them or spread to regional
lymph nodes or distant locations. Benign tumors are generally named according to the
tissues from which they arise and include the suffix -oma. Benign tumors do not cause
systemic symptoms.
PTS: 1 REF: Page 364